T Cell Delivery of Nanoparticles-Bound Anti-CD20 Monoclonal Antibody: Successful B Cell Depletion in the Spinal Cord during Experimental Autoimmune Encephalomyelitis.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology
Alberto CarnascialiClara Ballerini

Abstract

We developed a nanotechnology based-cell mediated drug delivery system by loading myelin antigen-specific T cells with nanoparticles bound to anti-CD20 monoclonal antibody. Anti-CD20 antibody is a current treatment (ocrelizumab) for multiple sclerosis (MS), a chronic, inflammatory and autoimmune disease of the central nervous system (CNS). CD20-depletion has been associated with efficacy in active relapsing and progressive MS, but may not efficiently target inflammatory cells compartmentalized in the CNS. In our work, the intravenous transfer of T cells containing nanoparticle-anti-CD20 complex in mice causes B cell depletion in the spleen and in the brain, whereas the injection of anti-CD20 alone depletes B cells only in the spleen. Testing this system in Experimental Autoimmune Encephalomyelitis (EAE), animal model of MS, we found that spinal cord B cell depletion ameliorates the disease course and pathology. Graphical Abstract.

References

Oct 24, 2002·Blood·James L RubensteinMarc A Shuman
Jun 17, 2005·Journal of Neuroimmunology·Fabrizio GiulianiV Wee Yong
Jan 18, 2006·Immunity·Falk Nimmerjahn, Jeffrey V Ravetch
Mar 8, 2006·The Journal of Experimental Medicine·Yasuhito HamaguchiThomas F Tedder
Sep 5, 2007·Molecular Immunology·Martin J GlennieRonald P Taylor
Sep 14, 2010·Journal of Neuroimmunology·Jami BennettStephen McQuaid
Feb 26, 2011·Expert Opinion on Drug Delivery·Elena V BatrakovaAlexander V Kabanov
Jan 30, 2014·Drug Delivery·Narayanan KasinathanJ Venkata Rao
Jul 1, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Elizabeth NanceRichard J Price
Nov 2, 2014·Central Nervous System Agents in Medicinal Chemistry·Kritika GoyalAkshay Anand
Jan 27, 2015·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Clara BalleriniPietro Maggi
Dec 10, 2015·Biomaterials Science·Tian-Tian ZhangWenzhen Liao
Apr 5, 2016·Annals of Clinical and Translational Neurology·Mika KomoriBibiana Bielekova
Dec 23, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yiqun ZhouRoger M Leblanc
Mar 21, 2018·Theranostics·Xiaowei Dong

❮ Previous
Next ❯

Software Mentioned

GraphPad Prism®
ImageJ
FloMax®
GraphPad
FACS Diva®

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Annals of Clinical and Translational Neurology
Klaus Lehmann-HornMartin S Weber
Nihon rinsho. Japanese journal of clinical medicine
Yumi Jo, Junji Suzumiya
International Journal of Clinical and Experimental Pathology
Marie M BockenstedtDouglas E Jones
© 2022 Meta ULC. All rights reserved